Skip to main content
TipRanks
Go Ultimate75% OFF

Sutro Biopharma (S090) Income Statement

1 Followers

Sutro Biopharma Income Statement

Last quarter (Q3 2026), Sutro Biopharma's total revenue was $9.10M, a decrease of 6.14% from the same quarter last year. In Q3, Sutro Biopharma's net income was $-31.49M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 102.48M$ 62.04M$ 153.73M$ 67.77M$ 61.88M
$ 95.16M$ 54.83M$ 146.91M$ 59.48M$ 52.11M
$ 200.11M$ 293.28M$ 236.19M$ 188.43M$ 150.63M
Depreciation and Amortization$ 7.32M$ 7.22M$ 6.82M$ 5.69M$ 4.84M
$ -145.65M$ -180.45M$ -67.92M$ -107.67M$ -97.56M
$ -104.95M$ -238.45M$ -89.28M$ -128.94M$ -98.52M
$ -86.23M$ 13.36M$ 677.00K$ 12.24M$ -7.01M
$ -191.18M$ -225.10M$ -88.60M$ -116.70M$ -105.54M
$ -191.09M$ -227.46M$ -106.79M$ -119.20M$ -105.54M
Per Share Metrics
Basic EPS$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Diluted EPS$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Weighted Average Shares Outstanding8.50M7.68M6.02M5.07M4.61M
Weighted Average Shares Outstanding (Diluted)8.50M7.68M6.02M5.07M4.61M

Currency in USD

Sutro Biopharma Earnings and Revenue History

-400M-200M0200M-450 %-300 %-150 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin